GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (NAS:OGI) » Definitions » EBIT

OrganiGram Holdings (OrganiGram Holdings) EBIT : $-176.05 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is OrganiGram Holdings EBIT?

OrganiGram Holdings's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-11.70 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-176.05 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. OrganiGram Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was -26.54%. OrganiGram Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -34.02%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. OrganiGram Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -108.07%.


OrganiGram Holdings EBIT Historical Data

The historical data trend for OrganiGram Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings EBIT Chart

OrganiGram Holdings Annual Data
Trend Apr12 Apr13 Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.37 29.04 2.86 -106.30 -101.39

OrganiGram Holdings Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.86 3.82 -5.52 -158.83 -11.70

Competitive Comparison of OrganiGram Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganiGram Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's EV-to-EBIT falls into.



OrganiGram Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-176.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrganiGram Holdings  (NAS:OGI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

OrganiGram Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: May. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-47.492 * ( 1 - 0% )/( (193.139 + 164.767)/ 2 )
=-47.492/178.953
=-26.54 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

OrganiGram Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: May. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-46.816/( ( (81.663 + max(62.696, 0)) + (73.181 + max(57.726, 0)) )/ 2 )
=-46.816/( ( 144.359 + 130.907 )/ 2 )
=-46.816/137.633
=-34.02 %

where Working Capital is:

Working Capital(Q: May. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(24.306 + 60.54 + 7.213) - (25.459 + 0 + 3.904)
=62.696

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(18.522 + 60.55 + 6.527) - (26.56 + 0 + 1.313)
=57.726

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

OrganiGram Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-176.051/162.904
=-108.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrganiGram Holdings EBIT Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


OrganiGram Holdings (OrganiGram Holdings) Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.